Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. The company's flagship product is LUPKYNIS, an approved treatment designed for adult individuals suffering from active lupus nephritis. Furthermore, Aurinia maintains a strategic collaboration and licensing agreement with Otsuka Pharmaceutical Co., Ltd. The firm's main corporate office is located in Victoria, Canada.
Show more...
FAQ
Aurinia Pharmaceuticals 今天的股價是多少?▼
AUPH 目前價格為 $16.10 USD,過去 24 小時下跌了 -0.74%。在圖表上更密切關注 Aurinia Pharmaceuticals 股票的表現。
Aurinia Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Aurinia Pharmaceuticals 的股票以代號 AUPH 進行交易。
Aurinia Pharmaceuticals 的股價在上漲嗎?▼
AUPH 股票較上週上漲 +2.49%,本月上漲 +5.04%,過去一年 Aurinia Pharmaceuticals 上漲 +102.91%。
Aurinia Pharmaceuticals 的市值是多少?▼
今天 Aurinia Pharmaceuticals 的市值為 2.14B
Aurinia Pharmaceuticals 下一次財報日期是什麼時候?▼
Aurinia Pharmaceuticals 將於 July 30, 2026 公布下一次財報。
Aurinia Pharmaceuticals 上一季度的財報如何?▼
AUPH 上一季度的財報為每股 0.25 USD,預估為 0.2 USD,帶來 +28.21% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Aurinia Pharmaceuticals 去年的營收是多少?▼
Aurinia Pharmaceuticals 去年的營收為 566.11MUSD。
Aurinia Pharmaceuticals 去年的淨利是多少?▼
AUPH 去年的淨收益為 574.4MUSD。
Aurinia Pharmaceuticals 有多少名員工?▼
截至 June 17, 2026,公司共有 130 名員工。
Aurinia Pharmaceuticals 位於哪個產業?▼
Aurinia Pharmaceuticals從事於Health & Wellness產業。
Aurinia Pharmaceuticals 何時完成拆股?▼
Aurinia Pharmaceuticals 最近沒有進行任何拆股。
Aurinia Pharmaceuticals 的總部在哪裡?▼
Aurinia Pharmaceuticals 的總部位於 美國 的 Edmonton。